PT 858: Charcot-Marie-Tooth Disease Case Study

This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (11/05/2023)

Original Editor -

Top Contributors -

Abstract[edit | edit source]

Introduction[edit | edit source]

This case study will examine a 25-year-old male diagnosed with type 1A Charcot-Marie-Tooth disease (CMT), also known as hereditary motor sensory neuropathy (HMSN). [1][2] CMT is the name given to a group of disorders characterized by sensory loss, muscle atrophy, and weakness due to peripheral nerve deterioration. [1] It is one of the most common hereditary conditions and can be inherited in one of three ways: autosomal dominant, autosomal recessive, or X-linked. In autosomal recessive CMT, the child would receive two mutated genes, one from each parent. Neither parent would have the disease, but they would be a carrier. In autosomal dominant CMT, the child would have a 50% chance of inheriting the disease from a carrier parent, and would only need to receive one copy of the mutated gene. In X-linked CMT, the mutation is associated with the “X” sex chromosome. Females have two “X” chromosomes, one from each parent, and males only have one, from their mother. This means that in X-linked CMT, a male child would have a 50% chance of receiving the mutated “X” chromosome from his mother. [3] A female child has the same chance of receiving the mutated “X” chromosome from their mother, however, they are likely to be less affected due to the random inactivation hypothesis proposed by Mary Lyon in 1961.[4]

The most common form of CMT is type 1 (CMT1), accounting for over 50% of cases. Of this, subtype 1A is the most prevalent. This is due to an extra copy or duplication of the peripheral myelin protein 22 (PMP22) gene.7 Scientists still don’t understand the exact implication of this extra copy; however, it is known that it alters the myelin sheaths of Schwann cells. There are other different types (CMT2, CMT4, CMTX and intermediate form) and subtypes, which can be seen in Figure ___.6

Symptoms of CMT1A vary among individuals, and onset occurs before 20 years old. The progression of the disease is gradual, and the feet are commonly affected first.5 Individuals noticed weakness, atrophy, and increased fatigue in the feet and legs.8 Therefore, it is common to see abnormalities develop like pes cavus, drop foot, and/or hammer toes.9 This can contribute to balance problems and increase the patient’s risks of falling. As the disease progresses, similar weakness and atrophy is seen in the hands and arms, leading to decreased dexterity. Additionally, it is common for individuals with CMT to experience sensory problems, such as decreased proprioception (position sense) and kinesthesia (movement sense). It is also common for patients to report pain, paresthesia, or reduced sensations in the extremities. As the disease progresses, there can be decreased sensation in hearing or vision.3 In severe cases, it may influence the diaphragm and respiration.5

The purpose of this case study is to provide readers with an example of how an individual may present with CMT and how physiotherapy can be used to help manage the condition. It is important to note that symptoms and severity can vary among individuals and interventions that work for one patient may not be successful for another patient2,3,10, however, this case study can provide a free and easily accessible reference to clinicians regarding patient symptoms and possible treatment options.

Client Characteristics[edit | edit source]

The patient is a 25-year-old male. He works as an accountant and recently moved to the city for a job. He was diagnosed with autosomal dominant Charcot-Marie-Tooth (CMT) disease type 1A by a neurologist at the at of 14. To manage his symptoms, he typically sees a physiotherapist once a month, however, due to the busyness of the move and his schedule, he was unable to see his physiotherapist for the 3 months leading up to moving and was unable to get an appointment with a new physiotherapist until now, one month after he moved. The patient has had multiple ankle sprains in the past 4 months, and in the past month has been unable to run due to an increased frequency of tripping over his own feet when increasing speed, in addition to general pain on the plantar surface of the foot. He reports feeling frustrated that he hasn’t be able to run and having a decreased mood. The patient self-referred to physiotherapy for maintenance of his condition and treatment.

Examination Findings[edit | edit source]

Subjective[edit | edit source]

History of Present Illness

In the past month, the patient has noticed that anytime he tried to increase his pace while walking, he found himself tripping over his feet and had to slow down to avoid falling. Prior to this, the patient reports tripping over his feet while running, and he believes this to be the cause of his recent sprained ankles. He reports that prior to 4 months ago, he would have ankle sprains occasionally, around once every year. However, in the past 4 months, he reports having one ankle sprain roughly every six weeks, with both ankles having been affected. The patient has not yet had any treatment for his ankle sprains, due to his missed appointments, but has received physiotherapy for treatment of CMT prior.

With respect to patient pain, he has reported an increase in plantar foot pain bilaterally in the past 3 months. The patient reports an increase in pain with walking over the last month. In addition, he also reports an increase in fatigue throughout the day, finding it more challenging to complete tasks around his home, such as cooking and cleaning.

Past Medical History

He was diagnosed with major depression disorder at 21.

The patient has had previous ankle sprains to both his left ankle (7 and 5 years ago) and his right ankle (4 and 3 years ago). He went to physio for the first ankle sprain 7 years ago, but not for the others.

In the past 4 months, he has had one sprain to his left ankle and 2 to his right ankle.

Medications

Ibuprofen (400 mg) 2 times per day for pain in ankles.

Fluoxetine (30 mg) once per day in the morning, though the patient reports that he often forgets to take it.

Health Habits

No history of smoking and consumes 2-3 alcoholic beverages per week.

Family History

His mother had autosomal dominant CMT type 1A, diagnosed when she was 16 years old.

Social History

The patient works as an accountant and lives alone in a one-bedroom apartment on the second floor of a building in a mid-sized city. There are 5 flights of stairs total inside the building, but there is an elevator. The patient’s parents and siblings live in another city around 3 hours away. Prior to his move, the patient frequently participated in a weekly run club. He has found a new run club to join since moving but has yet to join due to his current condition.

Functional History

The patient was independent in iADLs and bADLs. He did not use a gait aid, but has rearfoot varus wedge accommodative orthotics for his pes cavus. Prior to his ankle sprains, was running an average of 10-12 km per week and strength training 3 times each week .

Current Functional Status

He does not currently use gait aids or adaptive equipment, but is still wearing his orthotics. The patient feels he is moving slower and movements are more effortful, as well as that his sense of balance is not the same.

At home, he chooses to take the elevator instead of walking the 2 flights of stairs to his third floor apartment and in recent weeks, has found he is too tired to cook, which he enjoys doing, and orders take-out more than usual.

Objective[edit | edit source]

Depiction of Pes Cavus and Hammer Toes

Observation

-       Mild (R) mid-thoracic scoliosis

-       UE muscle tone appears normal

-       Bilateral pes cavus, more extreme arch of (R) foot, varus heel angle from posterior POV

-       Bilateral hammer toes

-       Distal mild muscle wasting of bilateral lower legs, stork inverted champagne bottle appearance notable on anterio-lateral leg

Range of Motion

Upper Extremity - All joints within normal limits for passive and active range

Lower Extremity - Hip extension: 14 degrees (R), 16 degrees (L); Ankle Dorsiflexion: 5 degrees (R), 6 degrees (L)

***all end feels normal

Manual Muscle Testing

Grade   /5  (R) Grade   /5  (L)
Hip Extension 4+ 4+
Hip Flexion 4 4
Knee Extension 5 5
Knee Flexion 4+ 5
Ankle Dorsiflexion 3 3+
Ankle Plantar Flexion 4 4
Ankle Inversion 3+ 3+
Ankle Eversion 5 5

Specific Muscle Strength Testing: determined tibialis anterior, extensor digitorum longus and extensor hallicus longus are primarily responsible for decreased strength of foot dorsiflexors and inverters

Neurological Assessment

Stocking Pattern of Sensory Neuropathy

Dermatomes: no deficits above the knee bilaterally. Below the knee does not follow a specific dermatomal pathway - patient presenting with altered sensation bilaterally following a stocking pattern.

UMN: Babinski (-), Hoffmann’s (-), Oppenheimer’s (-)

LMN/Deep Tendon Reflexes:

-       C6: Biceps Tendon– 2 (normal)

-       C7: Triceps Tendon– 2 (normal)

-       L3L4: Patellar Tendon – 2 (normal)

-       S1S2: Achilles Tendon – 1 (hyporeflexia)

Special Tests: Upper Extremity - Spurlings (-), Distraction (-), Vertebral Artery Test (-); Lower Extremity - Slump (-), Straight Leg Raise (-)

Sensation Testing:

A) Superficial Sensations: Light touch, temperature sense, and sharp/dull discrimination intact above the knee and impaired below the knee bilaterally.

B) Deep Sensations: Vibration sense intact above the knee and impaired below the knee bilaterally. Proprioreception/Kinesthesia impaired bilaterally for ankle dorsiflexion/plantarflexion.

Balance:

- Romberg Test (+) - loss of balance within 15 seconds with eyes open and 5 seconds with eyes closed

- Mini Best Score: 22/28

Observational Gait Analysis

Decreased stride length and increased time in double support were noted with no observable differences in stance phase, swing phase, or arm swing. There were noticeable bilateral pes cavus, distal mild bilateral lower legs, and anterior pelvic tilt. Increased compensation was observable at bilateral hips (hip hiking and circumduction). Bilateral mild foot drop was also observed. Using the 10m walk test, a gait speed of 1.2m/sec was calculated, which is lower than age normative values. Patient completed repeated heel walking for 20m, during the last 10m of the task bilateral reduction in ankle dorsiflexion was noted.

Outcome Measures

Clinical Impression[edit | edit source]

Analysis[edit | edit source]

Patient is a 25-year-old male with worsening lower extremity instability over the last 4 weeks that has impeded his ability to run. He presents with impaired balance, proprioception, reduced lower extremity strength, and overall reduced physical activity. Patient is a good candidate for physical therapy activities aimed at increasing strength of lower extremities, increasing dynamic balance, education on pacing, and optimizing participation in previously enjoyed physical activities.

Prognosis[edit | edit source]

Although the patient has CMT type 1A that will continue to progress, their previous high level of function plus activity, and young age are positive indicators for slowed progression of disability associated with his condition.

Problem List[edit | edit source]

Intervention[edit | edit source]

Patient-centered Treatment Goals[edit | edit source]

Management Program[edit | edit source]

Outcome[edit | edit source]

Discussion[edit | edit source]

Self-Study Questions[edit | edit source]

Additional Patient Resources[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1. Charcot-Marie-Tooth Disease (CMT) [Internet]. Muscular Dystrophy Association; 2021 [cited 2023 May 8]. Available from: https://www.mda.org/disease/charcot-marie-tooth
  2. 2. Reilly MM, Murphy SM, Laurá M. Charcot-Marie-Tooth disease. Journal of the Peripheral Nervous System. 2011 Apr 19;16(1):1–14. doi:10.1111/j.1529-8027.2011.00324.x
  3. 3. Charcot-Marie-Tooth Disease [Internet]. U.S. Department of Health and Human Services; 2023 [cited 2023 May 8]. Available from: https://www.ninds.nih.gov/health-information/disorders/charcot-marie-tooth-disease
  4. 4. Lyon MF. Gene action in the X-chromosome of the mouse (mus musculus L.). Nature. 1961 Apr 1961;190(4773):372–3. doi:10.1038/190372a0